Scientific Industries (SCND) stock price is $0.68, unchanged on the day, as of Oct 14, 2026. It has a market cap of $8.11Mn, and is classified in the Life Sciences Tools industry (Healthcare sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap8.11 Mn
P/E-10.94
P/S1.42
Div. Yield0.00
Revenue Growth (1y) (Qtr)36.02
Add ratio to table…
About
Scientific Industries, Inc. is engaged in the design, manufacture, and marketing of standard benchtop laboratory equipment and bioprocessing systems for research and industrial applications. The company, incorporated in 1954 and headquartered in Bohemia, New York, serves universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other research focused industries.
Revenue is derived from the sale of benchtop laboratory…
Scientific Industries, Inc. is engaged in the design, manufacture, and marketing of standard benchtop laboratory equipment and bioprocessing systems for research and industrial applications. The company, incorporated in 1954 and headquartered in Bohemia, New York, serves universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other research focused industries.
Revenue is derived from the sale of benchtop laboratory equipment such as pharmacy and laboratory balances, scales, force gauges, automated pill counters, and moisture analyzers under the Torbal® and VIVID® brands, as well as bioprocessing products including smart sensor integrated systems for biomass monitoring, automated feeding, and pH and dissolved oxygen measurement. The company sells these products through a direct sales force, a network of distributors, and online channels.
The company operates through the following segments:
Benchtop Laboratory Equipment and Weighing Instruments includes pharmacy and laboratory balances, scales, force gauges, automated pill counters, moisture analyzers, and related products sold through the Torbal® division and the VIVID® brand, primarily via distributors, online channels, and direct sales.
Bioprocessing Systems encompasses the design, development, manufacture, and marketing of smart sensor integrated products such as the Cell Growth Quantifier, Liquid Injection System, coaster systems, flow through cells, Multi Parameter Sensor, and Dissolved Oxygen sensor pills, marketed under the DOTS brand platform and sold mainly through a direct sales force and a network of distributors.
Scientific Industries, Inc. competes in a fragmented market where many rivals are larger and possess greater financial, production, and marketing resources.
The company’s customers consist of universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries conducting laboratory scale research. A single customer accounted for 31% of consolidated net revenues in 2025 and 23% in 2024, primarily purchasing VIVID® automated pill counters.
Sector:HealthcareSector rationaleThe company's primary revenue comes from the design and manufacture of medical and laboratory equipment, specifically pharmacy balances, automated pill counters, and bioprocessing systems for pharmaceutical companies and medical device manufacturers, which falls under Life Sciences Tools and Medical Supplies in Healthcare. A secondary sector of Industrials is justified because the company also manufactures general industrial weighing instruments and force gauges used in broader research and industrial applications.Industries:Life Sciences ToolsLife Sciences ToolsPrimaryScientific Industries designs and manufactures benchtop laboratory equipment and bioprocessing systems, such as biomass monitoring sensors and moisture analyzers, sold to universities and pharmaceutical companies for research. These products, including the DOTS brand platform and Torbal balances, are classic life-sciences research tools and bioprocessing supplies.DentalDentalSecondaryThe company sells automated pill counters under the VIVID brand specifically to pharmacies, which constitutes a material portion of its revenue, as evidenced by a single customer accounting for up to 31% of net revenues for these products.Classified using BQ-MICSCIK: 0000087802
Statement Business Segments Axis Breakdown of Revenue (2025)